Clinical Trial Update: Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis [Phase 2]

View source ↗

Summary

A randomized, double-blind Phase 2 trial evaluated the efficacy and safety of autologous HB-MSCs versus placebo in multiple sclerosis; results were posted in Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous HB-MSCs (bone marrow-derived mesenchymal stem cells (HB-MSCs))

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-07